Skip to main content
Premium Trial:

Request an Annual Quote

Asuragen, Novartis Team on RT-qPCR Tools

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Asuragen today said that it has entered into an exclusive collaboration with Novartis to develop tools intended to aid laboratories with standardization of BCR-ABL1 RT-qPCR testing to the international scale.

The Austin, Texas-based firm said that it would distribute the Armored RNA Quant BCR-ABL1 RNA International Scale calibrators and software reporting tools directly or through distributors worldwide.

"Our development of the BCR-ABL1 RNA IS Calibrators and software tool leverages both our expertise in molecular diagnostic assay development and our proprietary Armored RNA technology," Asuragen President Rollie Carlson noted in a statement.

Asuragen said that the calibrators are intended to be compatible with "several widely used assays, including both commercially available and laboratory developed tests."

Financial and other terms of the alliance were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more